Report Overview
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended.
There are no approved therapies to combat the debilitating symptoms of CIPN now. Current alternatives include Palliative care using antidepressants, antiepileptic drugs, or opioids, all of which have well known adverse side effects.
This report contains market size and forecasts of Chemotherapy Induced Peripheral Neuropathy Treatment in India, highlights the following information:
Sales of Chemotherapy Induced Peripheral Neuropathy Treatment in India: Value 2019 VS 2023 VS 2030, ($ millions)
Sales of Chemotherapy Induced Peripheral Neuropathy Treatment in India: Volume 2019 VS 2023 VS 2030, (K Units)
Sales of Chemotherapy Induced Peripheral Neuropathy Treatment in India: Revenue Market Share by Company, 2019-2024
Sales of Chemotherapy Induced Peripheral Neuropathy Treatment in India: Volume Market Share by Company, 2019-2024
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Chemotherapy Induced Peripheral Neuropathy Treatment will continue to grow rapidly in the future.
The global Chemotherapy Induced Peripheral Neuropathy Treatment market size was valued at 1675.1 million in 2023 and is forecast to a readjusted size of US$ 2599.2 million by 2030, with a CAGR of 6.4% during the forecast period 2024-2030.While the India Chemotherapy Induced Peripheral Neuropathy Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. India will account for % percent of Chemotherapy Induced Peripheral Neuropathy Treatment's global value in 2030, from % in 2023.
Our research team has surveyed the Chemotherapy Induced Peripheral Neuropathy Treatment manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, Value, demand, price change, product matrix, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
India Chemotherapy Induced Peripheral Neuropathy Treatment Market, By Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
India Chemotherapy Induced Peripheral Neuropathy Treatment Market Segment Percentages, By Type, 2023 (%)
Calcium Channel α2-delta Ligands
Antidepressants
Opioids
Others
India Chemotherapy Induced Peripheral Neuropathy Treatment Market, By Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
India Chemotherapy Induced Peripheral Neuropathy Treatment Market Segment Percentages, By Application, 2023 (%)
Platinum Agents
Taxanes
Vinca Alkaloids
Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chemotherapy Induced Peripheral Neuropathy Treatment revenues in India market, 2019-2024 (Estimated), ($ millions)
Key companies Chemotherapy Induced Peripheral Neuropathy Treatment sales in India market, 2019-2024 (Estimated), (K Units)
Further, the report presents profiles of competitors in the market, key players include:
Aptinyx Inc
Asahi Kasei Pharma Corp
Regenacy Pharmaceuticals
MAKScientific LLC
Metys Pharmaceuticals AG
Nemus Bioscience Inc
PledPharma
Sova Pharmaceuticals Inc
DermaXon LLC
Kineta Inc
Krenitsky Pharmaceuticals Inc
PeriphaGen
Apexian Pharma
WinSanTor
Market Size Overview
USD Million
-
2026-
2032-
CAGR (2024-2032)MARKET SIZE 2026
USD - MN
Million
MARKET SIZE 2032
USD - MN
Million
CAGR (2026-2032)
-
FASTEST GROWING REGION
Asia Pacific
LARGEST MARKET
Asia Pacific
Key Market Segmentation
By Purity Level
- 4N
- 5N
- 6N
- Others
By Application
- Semiconductor
- Display
- Solar
- Others
By End-User Industry
- Electronics
- Optoelectronics
- Photovoltaics
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Regional Market Insights
Asia Pacific
China, Japan, South Korea, Southeast Asia, India
North America
U.S., Canada, Mexico
Europe
Germany, France, UK, Italy
South America
Brazil, etc.
Middle East and Africa
Turkey, GCC Countries, Africa, etc.
Global Perspective. Local Insight.
Our reports deliver comprehensive regional coverage to help you understand market dynamics, identify growth opportunities, and make informed decisions.
VALUE YOU CAN TRUST
Why Buy This Report?
Actionable insights. Trusted data. Smarter decisions.
Everything you need to stay ahead with confidence.
01
Gain a comprehensive understanding of the market
02
Make informed business decisions with data-backed insights
03
Identify growth opportunities and emerging markets
04
Stay ahead of competitors with actionable intelligence
05
Support strategic planning and investment decisions
06
Access detailed market segmentation and regional analysis
07
Benchmark key players, pricing, and market share
08
Benefit from reliable forecasts, trends, and future outlook
09
Understand customer demand, sales potential, and industry dynamics
10
Save research time with expert-validated data and analysis
Need Customization?
Reliable Reports
Trusted by Leaders
Global Coverage
100+ Countries
24/7 Support
We're Here to Help
Secure Payments
Safe & Trusted